Study of Orelabrutinib in Combination With Gemox in Refractory / Relapsed Diffuse Large B-cell Lymphoma
Clinical trial NCT05381506 · UNKNOWN
Trial details
- NCT number
- NCT05381506
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2023-12-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.